M N Chang

1.3k total citations
20 papers, 951 citations indexed

About

M N Chang is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, M N Chang has authored 20 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in M N Chang's work include Acute Myeloid Leukemia Research (5 papers), Statistical Methods in Clinical Trials (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). M N Chang is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Statistical Methods in Clinical Trials (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). M N Chang collaborates with scholars based in United States, China and Switzerland. M N Chang's co-authors include Yaddanapudi Ravindranath, Howard J. Weinstein, C. Philip Steuber, Susana C. Raimondi, F G Behm, David L. Ahmann, A J Carroll, Mary V. Gresik, H. Samuel Wieand and S. Stephen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

M N Chang

17 papers receiving 915 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M N Chang United States 13 392 268 263 255 159 20 951
Jeffrey Skolnik United States 17 78 0.2× 554 2.1× 518 2.0× 69 0.3× 40 0.3× 32 1.2k
John H. Moon United States 8 129 0.3× 147 0.5× 188 0.7× 131 0.5× 21 0.1× 12 574
Nicole Gormley United States 18 397 1.0× 272 1.0× 362 1.4× 117 0.5× 34 0.2× 53 1.0k
Hedwig M. Blommestein Netherlands 16 253 0.6× 175 0.7× 296 1.1× 67 0.3× 22 0.1× 62 665
Fotios Siannis United Kingdom 17 92 0.2× 305 1.1× 659 2.5× 27 0.1× 65 0.4× 22 1.5k
Coldman Aj Canada 9 118 0.3× 345 1.3× 887 3.4× 142 0.6× 89 0.6× 10 1.6k
R.D. Gelber Switzerland 18 70 0.2× 129 0.5× 550 2.1× 58 0.2× 231 1.5× 31 1.0k
Jianchang Lin United States 18 182 0.5× 293 1.1× 395 1.5× 17 0.1× 8 0.1× 84 1.0k
Tu Xu United States 12 1.9k 4.9× 1.3k 4.8× 438 1.7× 481 1.9× 60 0.4× 29 2.4k
Yijie Zhou United States 10 487 1.2× 50 0.2× 287 1.1× 38 0.1× 66 0.4× 26 1.5k

Countries citing papers authored by M N Chang

Since Specialization
Citations

This map shows the geographic impact of M N Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M N Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M N Chang more than expected).

Fields of papers citing papers by M N Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M N Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M N Chang. The network helps show where M N Chang may publish in the future.

Co-authorship network of co-authors of M N Chang

This figure shows the co-authorship network connecting the top 25 collaborators of M N Chang. A scholar is included among the top collaborators of M N Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M N Chang. M N Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Na, M N Chang, Shidong Liu, & Bing Chen. (2025). Study on the changes and influencing factors of depression in Chinese women with cancer: an analysis based on CHARLS panel data. Frontiers in Public Health. 12. 1485196–1485196. 1 indexed citations
2.
Gejerman, Glen, Timothy T. Wheeler, John E. Sylvester, et al.. (2025). Phase 3, Randomized, Placebo Controlled Clinical Trial of CAN-2409+Prodrug in Combination with Standard of Care External Beam Radiation (EBRT) for Newly Diagnosed Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 123(1). S41–S41.
3.
Zhu, Hong, et al.. (2024). Clinical Effect Analysis and Prognostic Factors of Photodynamic Therapy for Cervical Precancerous Lesions. Journal of Biophotonics. 18(2). e202400454–e202400454.
4.
5.
Nakamura, Kaoru, John Pendleton, Satoshi Anai, et al.. (2011). Utility of Serial Urinalyses and Urinary Cytology in the Evaluation of Patients with Microscopic Haematuria. West African Journal of Medicine. 29(6). 384–7. 4 indexed citations
6.
George, Thomas J., et al.. (2006). A case-control study evaluating differences in resource utilization between diabetic and non-diabetic cancer patients undergoing chemotherapy. Journal of Clinical Oncology. 24(18_suppl). 6126–6126. 2 indexed citations
7.
Ravindranath, Yaddanapudi, M N Chang, C. Philip Steuber, et al.. (2005). Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia. 19(12). 2101–2116. 125 indexed citations
8.
9.
Fu, Sidney W., DD Ross, W. David Hankins, et al.. (2000). BP1, a new homeobox gene, is frequently expressed in acute leukemias. Leukemia. 14(11). 1867–1875. 45 indexed citations
10.
Raimondi, Susana C., M N Chang, Yaddanapudi Ravindranath, et al.. (1999). Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821.. Blood. 94(11). 3707–16. 235 indexed citations
11.
Parsons, Susan K., Shari Gelber, Bernard F. Cole, et al.. (1999). Quality-Adjusted Survival After Treatment for Acute Myeloid Leukemia in Childhood: A Q-TWiST Analysis of the Pediatric Oncology Group Study 8821. Journal of Clinical Oncology. 17(7). 2144–2144. 31 indexed citations
12.
Chang, M N, H. A. Guess, & Joseph F. Heyse. (1994). Reduction in burden of illness: A new efficacy measure for prevention trials. Statistics in Medicine. 13(18). 1807–1814. 38 indexed citations
13.
Chang, M N & Jonathan J. Shuster. (1994). Interim Analysis for Randomized Clinical Trials: Simulating the Predictive Distribution of the Log-Rank Test Statistic. Biometrics. 50(3). 827–827. 3 indexed citations
14.
Chang, M N. (1989). Confidence Intervals for a Normal Mean Following a Group Sequential Test. Biometrics. 45(1). 247–247. 39 indexed citations
15.
Creagan, Edward T., David L. Ahmann, Stephen Frytak, et al.. (1987). Three consecutive phase II studies of recombinant interferon alfa–2a in advanced malignant melanoma. Updated analyses. Cancer. 59(S3). 638–646. 37 indexed citations
16.
Morton, Roscoe F., Edward T. Creagan, Stephen A. Cullinan, et al.. (1987). Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanoma.. Journal of Clinical Oncology. 5(7). 1078–1082. 22 indexed citations
17.
Chang, M N, Terry M. Therneau, H. Samuel Wieand, & S. Stephen. (1987). Designs for Group Sequential Phase II Clinical Trials. Biometrics. 43(4). 865–865. 97 indexed citations
18.
Ingle, James N., James E. Krook, Lloyd K. Everson, et al.. (1986). Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer.. Journal of Clinical Oncology. 4(2). 178–185. 121 indexed citations
19.
Creagan, Edward T., David L. Ahmann, Stephen Frytak, et al.. (1986). Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients.. PubMed. 70(5). 619–24. 43 indexed citations
20.
Ingle, James N., David L. Ahmann, Harry J. Long, et al.. (1986). Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer.. Journal of Clinical Oncology. 4(6). 958–964. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey Skolnik Breakdown of academic impact, for papers by John H. Moon Breakdown of academic impact, for papers by Nicole Gormley Breakdown of academic impact, for papers by Hedwig M. Blommestein Breakdown of academic impact, for papers by Fotios Siannis Breakdown of academic impact, for papers by Coldman Aj Breakdown of academic impact, for papers by R.D. Gelber Breakdown of academic impact, for papers by Jianchang Lin Breakdown of academic impact, for papers by Tu Xu Breakdown of academic impact, for papers by Yijie Zhou
Rankless by CCL
2026